KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,853,226 | +90.3% | 10,960 | +144.0% | 0.01% | +66.7% |
| Q2 2023 | $973,873 | -69.9% | 4,491 | -72.7% | 0.00% | -76.9% |
| Q4 2022 | $3,235,373 | -37.1% | 16,465 | -28.0% | 0.01% | -50.0% |
| Q3 2022 | $5,145,000 | +1554.3% | 22,876 | +738.3% | 0.03% | +2500.0% |
| Q2 2021 | $311,000 | -79.6% | 2,729 | -81.8% | 0.00% | -90.9% |
| Q4 2020 | $1,522,000 | -13.2% | 14,982 | -34.0% | 0.01% | -54.2% |
| Q3 2020 | $1,754,000 | -73.1% | 22,684 | -61.2% | 0.02% | -77.1% |
| Q2 2020 | $6,520,000 | +1255.5% | 58,498 | +775.7% | 0.10% | +775.0% |
| Q1 2020 | $481,000 | – | 6,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |